(4S,17S)-4-benzyl-13-[2-(2-methyl-1,3-thiazol-4-yl)acetyl]-17-propan-2-yl-6-oxa-19-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraene-2,9,15-trione

C30H33N7O5S2 — CID 138387366

IUPAC(4S,17S)-4-benzyl-13-[2-(2-methyl-1,3-thiazol-4-yl)acetyl]-17-propan-2-yl-6-oxa-19-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraene-2,9,15-trione
SMILESCc1nc(CC(=O)N2CCNC(=O)c3coc(n3)[C@H](Cc3ccccc3)NC(=O)c3csc(n3)[C@H](C(C)C)NC(=O)C2)cs1
InChIInChI=1S/C30H33N7O5S2/c1-17(2)26-30-35-23(16-44-30)28(41)33-21(11-19-7-5-4-6-8-19)29-34-22(14-42-29)27(40)31-9-10-37(13-24(38)36-26)25(39)12-20-15-43-18(3)32-20/h4-8,14-17,21,26H,9-13H2,1-3H3,(H,31,40)(H,33,41)(H,36,38)/t21-,26-/m0/s1
InChIKeyGCZQBOJJMMSPAP-LVXARBLLSA-N
MW635.77 g/mol
LogP3.24
Rot. Bonds5

About (4S,17S)-4-benzyl-13-[2-(2-methyl-1,3-thiazol-4-yl)acetyl]-17-propan-2-yl-6-oxa-19-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraene-2,9,15-trione

(4S,17S)-4-benzyl-13-[2-(2-methyl-1,3-thiazol-4-yl)acetyl]-17-propan-2-yl-6-oxa-19-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraene-2,9,15-trione (PubChem CID 138387366) has the molecular formula C30H33N7O5S2 and a molecular weight of 635.77 g/mol. Its IUPAC name is (4S,17S)-4-benzyl-13-[2-(2-methyl-1,3-thiazol-4-yl)acetyl]-17-propan-2-yl-6-oxa-19-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraene-2,9,15-trione.

Molecular Properties

Compound Name(4S,17S)-4-benzyl-13-[2-(2-methyl-1,3-thiazol-4-yl)acetyl]-17-propan-2-yl-6-oxa-19-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraene-2,9,15-trione
PubChem CID138387366
Molecular FormulaC30H33N7O5S2
Molecular Weight635.77 g/mol
Exact Mass635.20
IUPAC Name(4S,17S)-4-benzyl-13-[2-(2-methyl-1,3-thiazol-4-yl)acetyl]-17-propan-2-yl-6-oxa-19-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraene-2,9,15-trione
SMILESCc1nc(CC(=O)N2CCNC(=O)c3coc(n3)[C@H](Cc3ccccc3)NC(=O)c3csc(n3)[C@H](C(C)C)NC(=O)C2)cs1
InChIInChI=1S/C30H33N7O5S2/c1-17(2)26-30-35-23(16-44-30)28(41)33-21(11-19-7-5-4-6-8-19)29-34-22(14-42-29)27(40)31-9-10-37(13-24(38)36-26)25(39)12-20-15-43-18(3)32-20/h4-8,14-17,21,26H,9-13H2,1-3H3,(H,31,40)(H,33,41)(H,36,38)/t21-,26-/m0/s1
InChIKeyGCZQBOJJMMSPAP-LVXARBLLSA-N
XLogP3.24
TPSA159.42 Ų
H-Bond Donors3
H-Bond Acceptors10
Rotatable Bonds5
Heavy Atoms44
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500635.77
LogP ≤ 53.24
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1010

Analyze (4S,17S)-4-benzyl-13-[2-(2-methyl-1,3-thiazol-4-yl)acetyl]-17-propan-2-yl-6-oxa-19-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraene-2,9,15-trione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (4S,17S)-4-benzyl-13-[2-(2-methyl-1,3-thiazol-4-yl)acetyl]-17-propan-2-yl-6-oxa-19-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraene-2,9,15-trione?
The IUPAC name of (4S,17S)-4-benzyl-13-[2-(2-methyl-1,3-thiazol-4-yl)acetyl]-17-propan-2-yl-6-oxa-19-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraene-2,9,15-trione (CID 138387366) is (4S,17S)-4-benzyl-13-[2-(2-methyl-1,3-thiazol-4-yl)acetyl]-17-propan-2-yl-6-oxa-19-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraene-2,9,15-trione.
What is the SMILES notation for (4S,17S)-4-benzyl-13-[2-(2-methyl-1,3-thiazol-4-yl)acetyl]-17-propan-2-yl-6-oxa-19-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraene-2,9,15-trione?
The canonical SMILES for (4S,17S)-4-benzyl-13-[2-(2-methyl-1,3-thiazol-4-yl)acetyl]-17-propan-2-yl-6-oxa-19-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraene-2,9,15-trione is Cc1nc(CC(=O)N2CCNC(=O)c3coc(n3)[C@H](Cc3ccccc3)NC(=O)c3csc(n3)[C@H](C(C)C)NC(=O)C2)cs1.
What is the InChIKey of (4S,17S)-4-benzyl-13-[2-(2-methyl-1,3-thiazol-4-yl)acetyl]-17-propan-2-yl-6-oxa-19-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraene-2,9,15-trione?
The InChIKey is GCZQBOJJMMSPAP-LVXARBLLSA-N. The full InChI is InChI=1S/C30H33N7O5S2/c1-17(2)26-30-35-23(16-44-30)28(41)33-21(11-19-7-5-4-6-8-19)29-34-22(14-42-29)27(40)31-9-10-37(13-24(38)36-26)25(39)12-20-15-43-18(3)32-20/h4-8,14-17,21,26H,9-13H2,1-3H3,(H,31,40)(H,33,41)(H,36,38)/t21-,26-/m0/s1.
What are the key properties of (4S,17S)-4-benzyl-13-[2-(2-methyl-1,3-thiazol-4-yl)acetyl]-17-propan-2-yl-6-oxa-19-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraene-2,9,15-trione?
(4S,17S)-4-benzyl-13-[2-(2-methyl-1,3-thiazol-4-yl)acetyl]-17-propan-2-yl-6-oxa-19-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraene-2,9,15-trione has a molecular weight of 635.77 g/mol, XLogP of 3.24, 5 rotatable bonds, 3 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for (4S,17S)-4-benzyl-13-[2-(2-methyl-1,3-thiazol-4-yl)acetyl]-17-propan-2-yl-6-oxa-19-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraene-2,9,15-trione is sourced from PubChem (CID 138387366), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).